Jonah Comstock

A recent column in the Harvard Business Review says that two kinds of business strategies will dominate in the gold rush-like healthcare economy of the future: Goldminers and Bartenders.

Sense.

Personalized medicine was a hot topic at the BIO conference in Philadelphia, but in a session on digital health and patient engagement, payer and provider panelists also talked about how, in order to really drive medication and treatment adherence, patient engagement also has to be personalized.

The prototype of ToSense's floor pad device, which is about twice the size of a normal weight scale La Jolla, California-based toSense, the connected vitals signs monitoring device company formerly known as Perminova, has two more multifunction digital health devices in the pipeline to follow up its recently FDA-cleared CoVa Monitoring System.

Dr.

Pfizer Head of Clinical Innovation Craig Lipset In 2011, Pfizer announced a novel clinical trial that would be fully remote, with every aspect of the trial being handled either online, over the phone, or by mail.

Innovation in digital health won’t come in a gradual, incremental way, but rather through dramatic re-imaginings of care.

McNeil Consumer Healthcare, the Johnson & Johnson subsidiary that makes over the counter medications like Tylenol and Zyrtec, has released a new mobile app, called Healthyday, that uses crowdsourced data to inform users about location-based allergy, cold, and flu trends.

Boston Children's Hospital has tapped John Brownstein, currently the director of the hospital's computational epidemiology group, as its new Chief Innovation Officer.

A study last year found that many people reported adverse drug events on Twitter.